60 Degrees Pharmaceuticals (Nasdaq: SXTP) Investor Webinar - January 8, 2026 скачать в хорошем качестве

60 Degrees Pharmaceuticals (Nasdaq: SXTP) Investor Webinar - January 8, 2026

In our exclusive live investor webinar, 60 Degrees Pharmaceuticals (Nasdaq: SXTP) CEO Geoff Dow provided a comprehensive update on the company’s commercial progress, clinical pipeline, and regulatory strategy as SXTP advances its FDA-approved antimalarial ARAKODA® (tafenoquine) and expands into the high-growth babesiosis market. Our discussion highlighted why SXTP represents a compelling microcap biotech opportunity focused on vector-borne diseases with significant unmet medical needs. 🔬 Key Topics: • Commercial performance and growth outlook for ARAKODA® in malaria prevention • Increasing off-label demand tied to chronic and relapsing babesiosis • Gross margin profile of 50-55% and scalable commercial model • Overview of three active babesiosis clinical trials currently enrolling patients • First confirmed cure using FDA-licensed blood bank assay in relapsing babesiosis • Yale and Mount Sinai clinical collaborations validating tafenoquine’s mechanism • Estimated 380,000 addressable U.S. babesiosis patients annually • Potential peak annual revenue of approximately $245M through 2035 • Breakthrough Therapy Designation request and upcoming FDA Type B meeting • Commercial expansion plans, including telehealth partnerships and broader pricing access • Capital strategy, ATM usage, and path toward potential profitability in 2027 💡 60 Degrees Pharmaceuticals is leveraging an FDA-approved asset with an established safety profile while pursuing a second indication in a rapidly expanding tick-borne disease market with no FDA-approved treatments. Management’s prior FDA success, active clinical trials, and near-term data catalysts position SXTP as an undervalued biotech with multiple potential value inflection points. 👉 60 Degrees Pharmaceuticals is a client of RedChip. To learn more about SXTP and to read our full disclosure, visit: https://www.SXTPinfo.com #SXTP #BiotechStocks #SmallCapStocks #MicroCapInvesting #HealthcareStocks #Babesiosis #Malaria #FDA #ClinicalTrials #InvestorWebinar #RedChip